perhexiline has been researched along with egtazic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bienvenüe, A; Favero, J; Lafont, V; Pécheur, EI; Philippot, JR; Sainte-Marie, J | 1 |
| Hata, R; Kato, Y; Kubota, E; Miyazaki, K; Ozawa, S; St-Pierre, Y; Tsukuda, M | 1 |
2 other study(ies) available for perhexiline and egtazic acid
| Article | Year |
|---|---|
Transferrin receptor functions as a signal-transduction molecule for its own recycling via increases in the internal Ca2+ concentration.
Topics: Antibodies; Apoproteins; Calcium; Calcium Channel Blockers; Calmodulin; Cell Line; Chelating Agents; Egtazic Acid; Humans; Iodine Radioisotopes; Nickel; Perhexiline; Phytohemagglutinins; Protein Binding; Receptors, Transferrin; Signal Transduction; Thymidine; Transferrin; Trifluoperazine | 1997 |
Acidic extracellular pH increases calcium influx-triggered phospholipase D activity along with acidic sphingomyelinase activation to induce matrix metalloproteinase-9 expression in mouse metastatic melanoma.
Topics: Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Line, Tumor; Chelating Agents; Desipramine; Egtazic Acid; Enzyme Activation; Extracellular Fluid; Hydrogen-Ion Concentration; Indolizines; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Melanoma; Mibefradil; Mice; NF-kappa B; Nimodipine; Perhexiline; Phenethylamines; Phospholipase D; Phosphorylation; Promoter Regions, Genetic; Sphingomyelin Phosphodiesterase | 2007 |